Real-Time Clinical Trials in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Real-Time Clinical Trials in Brazil

Real-Time Clinical Trials in Brazil – Clinical Research in Latin America

As a nation renowned for its vibrant culture, rich biodiversity, and growing economy, Brazil has also emerged as a leading player in the field of medical research. One of the groundbreaking approaches that has gained significant traction in the country is real-time clinical trials.

These dynamic and adaptive trials are revolutionizing the traditional landscape of drug development, offering tremendous potential for advancing healthcare and improving patient outcomes. In this blog, we will explore the significance of real-time clinical trials in Brazil, highlighting their transformative impact on the nation’s healthcare sector and their contributions to global medical advancements.

The Traditional Clinical Trial Landscape

Traditional clinical trials have been the cornerstone of medical research, providing essential data to evaluate the safety and efficacy of new treatments. However, these trials often have lengthy timelines and rigid protocols, resulting in delayed access to potentially life-saving therapies for patients in need.

Moreover, the conventional approach may not accommodate changes in the medical landscape or emerging scientific knowledge, limiting the ability to optimize treatment strategies during the trial.

Real-Time Clinical Trials: A Paradigm Shift

Real-time clinical trials, also known as adaptive trials, represent a paradigm shift in medical research. These trials embrace flexibility and responsiveness, allowing researchers to make real-time adjustments to the study design based on emerging data. This adaptability enables rapid optimization of treatment protocols, leading to more efficient decision-making, reduced costs, and improved patient safety.

Benefits of Real-Time Clinical Trials in Brazil

  1. Accelerating Drug Development: By shortening the duration of clinical trials, real-time trials expedite the availability of new treatments to patients in Brazil. This acceleration is particularly critical for patients suffering from life-threatening conditions, as it can offer them access to potentially life-saving therapies at an earlier stage.
  2. Personalized Medicine: Real-time clinical trials enable researchers to tailor treatment protocols based on individual patient responses and genetic profiles. This personalized medicine approach increases the likelihood of successful outcomes and reduces the risk of adverse reactions, leading to better patient care.
  3. Enhancing Patient Safety: The flexibility of real-time trials allows researchers to swiftly address safety concerns and adapt treatment protocols accordingly. By prioritizing patient safety, real-time clinical trials minimize risks for participants and improve the overall quality of the study.
  4. Cost-Efficiency: Optimized trial designs and reduced timelines in real-time clinical trials lead to cost savings for pharmaceutical companies and healthcare providers. These savings can potentially translate into more affordable treatments, making them accessible to a broader population.
  5. Global Collaboration: Brazil’s adoption of real-time clinical trials has attracted international attention and collaboration from pharmaceutical companies and researchers. This global collaboration fosters knowledge exchange and investments in the nation’s healthcare sector, further enhancing the potential for medical breakthroughs.

Real-Time Clinical Trials in Brazil

Real-Time Clinical Trials in Brazil

Real-Time Clinical Trials in Brazil

Case Study: Real-Time Trials during the COVID-19 Pandemic

The COVID-19 pandemic served as a pivotal moment for real-time clinical trials in Brazil. The nation’s proactive approach allowed researchers to rapidly assess potential treatments and vaccines for the virus, expediting the development and approval process.

Through real-time clinical trials, Brazilian researchers evaluated various therapeutic candidates, such as antiviral drugs and immunomodulators, to combat COVID-19. The adaptive design enabled them to optimize treatment protocols based on emerging data, leading to timely interventions that helped mitigate the impact of the pandemic on the nation’s healthcare system.

Challenges and Future Outlook

While real-time clinical trials offer substantial advantages, they also present unique challenges. The dynamic nature of these trials requires close collaboration between researchers, regulatory bodies, and pharmaceutical companies. Ensuring proper training and resources are available is crucial to ensure the success of real-time trials and maintain ethical standards.

As Brazil continues to adopt real-time clinical trials, regulatory agencies must remain agile in adapting guidelines to accommodate this innovative approach while safeguarding patient welfare and data privacy. Additionally, fostering a culture of research collaboration and investment will be essential in sustaining Brazil’s position as a key player in medical progress and innovation.


Real-time clinical trials have emerged as a transformative force in medical research, and Brazil’s proactive approach in adopting this approach has the potential to reshape the nation’s healthcare landscape. By accelerating drug development, advancing personalized medicine, and encouraging global collaboration, real-time trials offer new hope for patients across Brazil.

With continued support and investment in this cutting-edge approach, Brazil is poised to make significant contributions to global healthcare advancements and improve the well-being of its population for years to come.

Real-Time Clinical Trials in Brazil

Source: Duke Clinical Research Institute

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Real-Time Clinical Trials in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Real-Time Clinical Trials in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Real-Time Clinical Trials in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Real-Time Clinical Trials in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Real-Time Clinical Trials in Brazil

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Real-Time Clinical Trials in Brazil

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Real-Time Clinical Trials in Brazil

The Cohortias Team

Real-Time Clinical Trials in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Real-Time Clinical Trials in Brazil

Network & Partnerships